Posted on 10/16/2021 1:41:50 AM PDT by blueplum
true. But it’s the first study to put out actual numbers for t-cell levels. And that advances our knowledge.
I think it’s pretty exciting we’re seeing infectious disease science, and our understanding of the immune system, evolve in real time, with scientists around the world all working on the same thing at the same time. It’s remarkable. Like watching the LaPalma volcano.
Elon Musk (Musk Foundation) is one of the funders, fwiw.
How big a random sample size would be better? Would you expect lower t-cell titers with a larger sample or higher t-cell titers?
The random sample of 61 subjects is small for sure ( 31P/22M/8J), but isn’t it still reflective of vaccine distribution in the US (J&J being the least distributed) ?
the lancet study is looking at antibody level fading
This counting study is diving two levels deeper in the immune system to T-cells (T-cells, or ‘trigger cells’ order the B cells to manufacture antibodies.)
At the least, the numbers might be useful for those who got T-cell tests on their own and are curious how their numbers compare. I’m hoping a lot of folk will be really happy with their results as a way to help document natural immunity.
Re #55 - Are waning antibodies even a negative in anyone other than elderly/compromised? I’d be for boosters for immunocompromised who have poor antibody production out the gate, but one size fits all every six or 8 months? I don’t see the point at the moment if there’s no morbidity factors. Unless incubation time drops below 5 days. (Guessing it takes at least 5 days for the immune system to ramp back up to overdrive). I think that’s where t-cells are a factor- how fast will they trigger the B cells into action?
If we don’t know when the virus will burn down to scattered campfire level, which could be a month or 12 months, is there another door yet to look behind? How far inside the mechanics of T-cells can we go? Are we better off continuing to use monoclonals after exposure, or even the pill forms being talked about now? As a moderate-risk person, I personally would choose monoclonals, assistance that doesn’t tax immune system resources AFAIK, over a booster, which obviously forces the immune system to work harder and use more resources (building blocks).
Vaccination Rates Not Linked to Lower COVID Rates, Epidemiology Paper Finds
A new paper in the European Journal of Epidemiology that analyzed 168 countries and 2,947 US counties found that higher vaccination rates were not associated with fewer COVID-19 cases.
https://fee.org/articles/vaccination-rates-not-linked-to-lower-covid-rates-epidemiology-paper-finds/
61 participants tested. Anecdotal.
... and doesn’t this go against the narrative that the vaxxed must be protected from the unvaxxed? ... that the unvaxxed are worthy of shame, shunning, and not entitled to their livelihood anymore?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.